Csequence Insights
Stay Informed and Educated with Csequence’s Blog
Raelina Krikston: Creative Intelligence for the Cannabis Market
Raelina Krikston uses her talents to create educational material for consumers. Her understanding of the changing climate within the cannabis industry makes her a key visionary on the Csequence team.
Monthly Journal Club – October 7, 9:00 AM PT
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s edition will feature Dr. Joshua Rein as he discusses his research and clinical experience with cannabis & kidney function.
The Banking Bill. More money for hemp research. The impact of decriminalization and changes at the NCAA.
It’s all about the banking bill this week, GOP senators push back as the SAFER banking bill emerges from committee, while state legislators signal their support. Virginia Tech receives a large grant to explore hemp genetics. Meanwhile, a new study shows decriminalization of cannabis doesn’t lead to increased deaths. And following the lead of the NFL, AFL and MLB, the NCAA recommends suspending testing for cannabinoids.
The Role of CBD in Lowering Blood Pressure: A Closer Look at HYPER-H21-4 Trial
In this study, the researchers wanted to see if changes in a substance called “serum urotensin-II” might be related to the effects of CBD on blood pressure. Serum urotensin-II is a substance in the body that can narrow blood vessels, leading to higher blood pressure. By studying this substance, the scientists hoped to understand how CBD might affect blood pressure regulation.
Cannabis and the Barriers to Clinical Trials
There are formidable challenges in conducting studies involving cannabis. Understanding Clinical Trials Before we delve into the complexities of cannabis clinical trials, let's establish what clinical trials are. These rigorous scientific experiments play a vital role...
Talk in Congress about reclassifying marijuana and banking, a warning from California, and changing attitudes
Everyone is talking about the reclassification marijuana. While a congressional report predicted that the DEA would follow HHS recommendations, Op-eds around the country raised questions about the future of marijuana. Lawmakers inched closer to a committee vote on a marijuana banking bill. The state of California weighs in on testing and a great selection of charts shows rapidly changing attitudes towards cannabis.
The Senate Pushes Back, The DEA in a Pinch and Changes in States and Abroad
In response to last week’s Health and Human Services (HHS) announcement 14 Senators authored a letter to the Drug Enforcement Agency (DEA)asking them to reject the recommendation to reschedule cannabis. A brief look at what rescheduling might mean. In the wake of this recommendation, the DEA fired an agent for using CBD. Meanwhile, US states consider plans for creating or funding reference labs to address ongoing issues with inaccurate, unregulated testing. A round-up of the questions the EU faces about marijuana legalization. A study raises questions about downstream effects for marijuana users.
HHS Recommends Rescheduling Marijuana and Sha’Carri Richardson is Fast without THC
The most significant development this week revolves around the recommendation by the Department of Health and Human Services (HHS) to reclassify marijuana as a Schedule III drug. In addition to this noteworthy announcement, there are a couple of other intriguing highlights to mention. A study conducted in Georgia has unveiled a profound impact on foster care resulting from the legalization of marijuana.
Legislators Move Toward More Regulation and Middle-Aged Americans Using More Marijuana
More evidence this week that attitudes toward cannabis are changing, a study out this week showed that marijuana use is at a record high among middle-aged Americans. As Ohio moves towards legalization, California stumbles in implementing its 2016 ballot proposition, leaving medicinal users out in the cold. Growers adopt a more scientific approach to harvesting.
Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer and Differing Opinions among Consumers, Regulators and the Judiciary.
As consumers signaled an erosion of the stigma behind marijuana use while a Supreme Court judge issues an injunction to an NY dispensary. Six companies received warnings from FDA and FTC for selling food products containing Delta 8 THC. Meanwhile, a store owner in PA...